Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$517M |
| 2 |
NXP Semiconductors
NXPI
|
+$351M |
| 3 |
Oracle
ORCL
|
+$279M |
| 4 |
Palo Alto Networks
PANW
|
+$268M |
| 5 |
Boston Scientific
BSX
|
+$204M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CERN
Cerner Corp
CERN
|
+$517M |
| 2 |
ExxonMobil
XOM
|
+$385M |
| 3 |
Cenovus Energy
CVE
|
+$292M |
| 4 |
PLAN
Anaplan, Inc.
PLAN
|
+$236M |
| 5 |
Phillips 66
PSX
|
+$222M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.01% |
| 2 | Technology | 7.76% |
| 3 | Financials | 7.66% |
| 4 | Healthcare | 7.12% |
| 5 | Industrials | 5.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Dillards
DDS
$9.69B
| $3.93M | ﹤0.01% |
17,808
-8,987
| -34% | -$2.59M |
|
3002
PUT
Colgate-Palmolive
CL
$72.3B
| $3.93M | ﹤0.01% |
49,000
| – | – |
|
3003
CALL
RingCentral
RNG
$5.79B
| $3.92M | ﹤0.01% |
75,000
| – | – |
|
3004
Q2 Holdings
QTWO
$4.06B
| $3.92M | ﹤0.01% |
101,495
+29,619
| +41% | +$1.44M |
|
|
ATCX
3005
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
| $3.91M | ﹤0.01% |
743,725
+13,154
| +2% | +$124K |
|
|
TPH
3006
DELISTED
Tri Pointe Homes
TPH
| $3.91M | ﹤0.01% |
231,686
+168,021
| +264% | +$3.3M |
|
|
SHOE
3007
Shoe Station Group
SHOE
$372M
| $3.88M | ﹤0.01% |
179,553
+159,531
| +797% | +$4.54M |
|
3008
Gladstone Capital
GLAD
$449M
| $3.88M | ﹤0.01% |
+192,168
| New | +$4.35M |
|
|
BRD
3009
DELISTED
Beard Energy Transition Acquisition Corp.
BRD
| $3.88M | ﹤0.01% |
+390,000
| New | +$3.87M |
|
3010
Cornerstone Strategic Value Fund
CLM
$2.07B
| $3.87M | ﹤0.01% |
+457,955
| New | +$4.9M |
|
3011
PUT
Builders FirstSource
BLDR
$7.29B
| $3.87M | ﹤0.01% |
+72,000
| New | +$4.42M |
|
3012
Celldex Therapeutics
CLDX
$3.07B
| $3.87M | ﹤0.01% |
143,343
+35,642
| +33% | +$1.04M |
|
|
TWO
3013
DELISTED
Two Harbors Investment
TWO
| $3.87M | ﹤0.01% |
194,032
+189,081
| +3,819% | +$3.83M |
|
3014
ESAB
ESAB
$4.75B
| $3.86M | ﹤0.01% |
+88,291
| New | +$4.26M |
|
3015
Limoneira
LMNR
$250M
| $3.86M | ﹤0.01% |
+274,066
| New | +$3.45M |
|
|
AMPI
3016
DELISTED
Advanced Merger Partners Inc
AMPI
| $3.86M | ﹤0.01% |
394,713
| – | – |
|
3017
STAAR Surgical
STAA
$1.11B
| $3.86M | ﹤0.01% |
54,395
-101,578
| -65% | -$6.54M |
|
3018
Tenable Holdings
TENB
$4.15B
| $3.86M | ﹤0.01% |
84,934
-310,497
| -79% | -$16M |
|
|
NEUE
3019
DELISTED
NeueHealth
NEUE
| $3.84M | ﹤0.01% |
26,370
+6,245
| +31% | +$909K |
|
|
CIR
3020
DELISTED
CIRCOR International, Inc
CIR
| $3.83M | ﹤0.01% |
233,644
+225,055
| +2,620% | +$4.5M |
|
3021
Stryker
SYK
$127B
| $3.82M | ﹤0.01% |
19,203
-54,846
| -74% | -$12.9M |
|
3022
PUT
Teladoc Health
TDOC
$1.18B
| $3.82M | ﹤0.01% |
115,000
-574,500
| -83% | -$24.4M |
|
|
RADI
3023
CALL
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $3.81M | ﹤0.01% |
+250,000
| New | +$3.6M |
|
3024
Bankwell Financial Group
BWFG
$531M
| $3.81M | ﹤0.01% |
122,794
+15,997
| +15% | +$538K |
|
|
APCA
3025
DELISTED
AP Acquisition Corp
APCA
| $3.81M | ﹤0.01% |
380,353
+152,900
| +67% | +$1.53M |
|
Similar funds
Israel Englander's Q2 2022 Portfolio in Review
As of Q2 2022, Israel Englander held 7,971 positions worth $161B, down 15% from $189B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Israel Englander deployed $8.78B of net new capital in Q2 2022, opening 1,144 new positions and adding to 2,588 existing holdings. Its largest new stake was M&T Bank: 828,809 shares worth $132M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 60% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was ExxonMobil, an estimated $385M trimmed.
- Israel Englander's largest Q2 2022 buy was M&T Bank: 828,809 shares worth $132M.
- Israel Englander added most to Invesco QQQ Trust in Q2 2022, an estimated $517M increase.
- Israel Englander's biggest Q2 2022 reduction was ExxonMobil, cutting an estimated $385M.
- Israel Englander fully exited Cerner Corp in Q2 2022, selling an estimated $517M.
- Israel Englander's ten largest holdings make up 23% of its $161B portfolio in Q2 2022.
- Israel Englander opened 1,144 new positions and closed 1,065 in Q2 2022.
- Israel Englander's portfolio value fell 15% quarter-over-quarter to $161B.
Based on Millennium Management's 13F filing for Q2 2022, filed 15 Aug 2022.